A technique for the specific enrichment of citrulline-containing peptides

Analytical Biochemistry

Volumn 403, Issue 1-2, 2010, Pages 43-51

  Tutturen, Astrid E V ^a   Holm, Anders ^b   Jørgensen, Marit ^b   Stadtmüller, Patricia ^a   Rise, Frode ^a   Fleckenstein, Burkhard ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chemical modification; Enrichment; NMR; Peptidylarginine deiminase; Protein citrullination; Rheumatoid arthritis

Indexed keywords

BLAST ENRICHMENT; CELL CULTURE; CHEMICAL MODIFICATION; DISEASES; MAMMALS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE;

BOVINE SERUM ALBUMINS; CYTOSOLIC FRACTIONS; MYELIN BASIC PROTEIN; PEPTIDYLARGININE DEIMINASE; POST-TRANSLATIONAL MODIFICATIONS; PROTEOMIC STUDIES; RHEUMATOID ARTHRITIS; SELECTIVE IMMOBILIZATION;

PEPTIDES;

4 HYDROXYPHENYLGLYOXAL; BOVINE SERUM ALBUMIN; CITRULLINE; ENDOPROTEINASE LYSC; GLYOXAL DERIVATIVE; MYELIN BASIC PROTEIN; PROTEIN ARGININE DEIMINASE; PROTEINASE; UNCLASSIFIED DRUG; 4-HYDROXYPHENYLGLYOXAL; HYDROLASE; PEPTIDE; PEPTIDYLARGININE DEIMINASE TYPE IV; PHENYLGLYOXAL;

ARTICLE; CONTROLLED STUDY; ENRICHMENT CULTURE; ENZYME IMMOBILIZATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PH; PRIORITY JOURNAL; PROTEIN CITRULLINATION; PROTEIN PROCESSING; AMINO ACID SEQUENCE; ANALOGS AND DERIVATIVES; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; TUMOR CELL LINE; VALIDATION STUDY;

BOVINAE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CHEMISTRY TECHNIQUES, ANALYTICAL; CITRULLINE; HUMANS; HYDROLASES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MYELIN BASIC PROTEIN; PEPTIDES; PHENYLGLYOXAL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77953361021     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.04.012     Document Type: Article

References (33)

1. Vossenaar E.R., Zendman A.J., van Venrooij W.J., Pruijn G.J. PAD, a growing family of citrullinating enzymes: genes, features, and involvement in disease. Bioessays 2003, 25:1106-1118.
2. Gyorgy B., Toth E., Tarcsa E., Falus A., Buzas E.I. Citrullination: a posttranslational modification in health and disease. Intl. J. Biochem. Cell Biol. 2006, 38:1662-1677.
3. Tarcsa E., Marekov L.N., Mei G., Melino G., Lee S.C., Steinert P.M. Protein unfolding by peptidylarginine deiminase: substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J. Biol. Chem. 1996, 271:30709-30716.
4. Proost P., Loos T., Mortier A., Schutyser E., Gouwy M., Noppen S., Dillen C., Ronsse I., Conings R., Struyf S., Opdenakker G., Maudgal P.C., Van D.J. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J. Exp. Med. 2008, 205:2085-2097.
5. Loos T., Opdenakker G., Van D.J., Proost P. Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation. Haematologica 2009, 94:1346-1353.
6. Pritzker L.B., Joshi S., Gowan J.J., Harauz G., Moscarello M.A. Deimination of myelin basic protein: I. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 2000, 39:5374-5381.
7. Senshu T., Kan S., Ogawa H., Manabe M., Asaga H. Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem. Biophys. Res. Commun. 1996, 225:712-719.
8. Asaga H., Yamada M., Senshu T. Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem. Biophys. Res. Commun. 1998, 243:641-646.
9. Makrygiannakis D., af Klint E., Lundberg I.E., Lofberg R., Ulfgren A.K., Klareskog L., Catrina A.I. Citrullination is an inflammation-dependent process. Ann. Rheum. Dis. 2006, 65:1219-1222.
10. Yamada R., Suzuki A., Chang X., Yamamoto K. Citrullinated proteins in rheumatoid arthritis. Front. Biosci. 2005, 10:54-64.
11. Klareskog L., Ronnelid J., Lundberg K., Padyukov L., Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 2008, 26:651-675.
12. Moscarello M.A., Wood D.D., Ackerley C., Boulias C. Myelin in multiple sclerosis is developmentally immature. J. Clin. Invest. 1994, 94:146-154.
13. Schellekens G.A., de Jong B.A., van den Hoogen F.H., van de Putte L.B., van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 1998, 101:273-281.
14. Raptopoulou A., Sidiropoulos P., Katsouraki M., Boumpas D.T. Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit. Rev. Clin. Lab. Sci. 2007, 44:339-363.
15. Szodoray P., Szabo Z., Kapitany A., Gyetvai A., Lakos G., Szanto S., Szucs G., Szekanecz Z. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun. Rev. 2009, 9:140-143.
16. Senshu T., Sato T., Inoue T., Akiyama K., Asaga H. Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal. Biochem. 1992, 203:94-100.
17. Makrygiannakis D., Hermansson M., Ulfgren A.K., Nicholas A.P., Zendman A.J., Eklund A., Grunewald J., Skold C.M., Klareskog L., Catrina A.I. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann. Rheum. Dis. 2008, 67:1488-1492.
18. Matsuo K., Xiang Y., Nakamura H., Masuko K., Yudoh K., Noyori K., Nishioka K., Saito T., Kato T. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res. Ther. 2006, 8:R175.
19. Holm A., Rise F., Sessler N., Sollid L.M., Undheim K., Fleckenstein B. Specific modification of peptide-bound citrulline residues. Anal. Biochem. 2006, 352:68-76.
20. Stensland M., Holm A., Kiehne A., Fleckenstein B. Targeted analysis of protein citrullination using chemical modification and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:2754-2762.
21. Hao G., Wang D., Gu J., Shen Q., Gross S.S., Wang Y. Neutral loss of isocyanic acid in peptide CID spectra: a novel diagnostic marker for mass spectrometric identification of protein citrullination. J. Am. Soc. Mass Spectrom. 2008, 20:723-727.
22. Stensland M.E., Pollmann S., Molberg O., Sollid L.M., Fleckenstein B. Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4. Biol. Chem. 2009, 390:99-107.
23. Arshady R., Atherton E., Clive D.L.J., Sheppard R.C. Peptide-synthesis: I. Preparation and use of polar supports based on poly(dimethylacrylamide). J. Chem. Soc. Perkin Trans. 1981, 1:529-537.
24. Cagney G., Amiri S., Premawaradena T., Lindo M., Emili A. In silico proteome analysis to facilitate proteomics experiments using mass spectrometry. Proteome Sci. 2003, 1:5-19.
25. Wood D.D., Ackerley C.A., Brand B., Zhang L., Raijmakers R., Mastronardi F.G., Moscarello M.A. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Lab. Invest. 2008, 88:354-364.
26. Posewitz M.C., Tempst P. Immobilized gallium(III) affinity chromatography of phosphopeptides. Anal. Chem. 1999, 71:2883-2892.
27. Zhang H., Li X.J., Martin D.B., Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labelling, and mass spectrometry. Nat. Biotechnol. 2003, 21:660-666.
28. Ficarro S.B., McCleland M.L., Stukenberg P.T., Burke D.J., Ross M.M., Shabanowitz J., Hunt D.F., White F.M. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 2002, 20:301-305.
29. Gao Y., Wang Y. Site-selective modifications of arginine residues in human hemoglobin induced by methylglyoxal. Biochemistry 2006, 45:15654-15660.
30. Stark G.R., Stein W.H., Moore S. Reactions of cyanate present in aqueous urea with amino acids and proteins. J. Biol. Chem. 1960, 235:3177-3181.
31. Wang Z., Nicholls S.J., Rodriguez E.R., Kummu O., Horkko S., Barnard J., Reynolds W.F., Topol E.J., DiDonato J.A., Hazen S.L. Protein carbamylation links inflammation, smoking, uremia, and atherogenesis. Nat. Med. 2007, 13:1176-1184.
32. Husgafvelpursiainen K., Sorsa M., Engstrom K., Einisto P. Passive smoking at work: biochemical and biological measures of exposure to environmental tobacco-smoke. Intl. Arch. Occup. Environ. Health 1987, 59:337-345.
33. Klareskog L., Padyukov L., Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr. Opin. Rheumatol. 2007, 19:49-54.